ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39 | -15.2% | 50,061 | 0.0% | 0.00% | – |
Q2 2023 | $46 | -100.0% | 50,061 | -85.3% | 0.00% | – |
Q3 2022 | $366,000 | -14.9% | 340,068 | +34.6% | 0.00% | – |
Q2 2022 | $430,000 | – | 252,682 | +2297009.1% | 0.00% | – |
Q3 2021 | $0 | – | 11 | -77.6% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 49 | -99.4% | 0.00% | – |
Q1 2021 | $43,000 | 0.0% | 8,189 | +2.5% | 0.00% | – |
Q4 2020 | $43,000 | -27.1% | 7,988 | +7.9% | 0.00% | – |
Q3 2020 | $59,000 | -20.3% | 7,400 | 0.0% | 0.00% | – |
Q2 2020 | $74,000 | +270.0% | 7,400 | 0.0% | 0.00% | – |
Q1 2020 | $20,000 | +1900.0% | 7,400 | +1306.8% | 0.00% | – |
Q4 2019 | $1,000 | -50.0% | 526 | -68.0% | 0.00% | – |
Q3 2019 | $2,000 | -50.0% | 1,643 | +88.6% | 0.00% | – |
Q1 2019 | $4,000 | +100.0% | 871 | +221.4% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 271 | +367.2% | 0.00% | – |
Q3 2018 | $1,000 | -99.8% | 58 | -99.8% | 0.00% | – |
Q2 2018 | $417,000 | +3.5% | 35,111 | -2.3% | 0.00% | – |
Q1 2018 | $403,000 | +72.2% | 35,951 | +2.4% | 0.00% | – |
Q4 2017 | $234,000 | -24.0% | 35,100 | -6.6% | 0.00% | – |
Q3 2017 | $308,000 | – | 37,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |